Search

Obtenga más información acerca del VPH y del riesgo de contraer cáncer en la comunidad hispana, que es la que tiene más casos de cáncer vinculado con la enfermedad en comparación con todos los demás grupos de los Estados Unidos.

… Tuesday, February 19, 2019 Resumen Un especialista de MSK explica por qué el VPH provoca más cáncer entre los hispanos que entre cualquier otro grupo, y cómo el hecho de hacer que más personas se vacunen contra el virus puede mejorar la salud pública. La vacuna contra el virus del papiloma humano (VPH

Leadership and staff from Memorial Sloan Kettering Cancer Center (MSK) joined leaders from New York Cancer & Blood Specialists (NYCBS) and Memorial Medical Care, PC (MMC), a practice of MSK physicians, to celebrate the recent opening of a new cancer care practice in the Flatbush section of Brooklyn.

… Wednesday, April 19, 2023 In early April, leadership and staff from Memorial Sloan Kettering Cancer Center (MSK) joined leaders from New York Cancer & Blood Specialists (NYCBS) and Memorial Medical Care, PC (MMC), a practice of MSK physicians, to celebrate the recent opening of a new cancer care practice

A glimpse into the world of two Gerstner Sloan Kettering Graduate School students.

… Sunday, March 1, 2009 Summary A glimpse into the world of two Gerstner Sloan Kettering Graduate School students. On January 13, Armine Matevossian , a first-year student at the Gerstner Sloan Kettering Graduate School of Biomedical Sciences , was already in the second week of her second laboratory rotation

Learn about how our donor community is funding life-changing cancer research at Memorial Sloan Kettering and ensuring a brighter future for people with cancer around the world.

… Friday, October 1, 2021 Every day, your dollars are accelerating today’s most daring discoveries straight into lifesaving care. Read more to learn about your impact. The Society’s 2021–2022 Campaign The Society of Memorial Sloan Kettering has supported cancer research, patient care, and education at

Dr. Marks was a towering figure who left a profound legacy.

… Friday, May 8, 2020 Summary Former Memorial Sloan Kettering President Paul Marks, who died April 28, 2020, was influential in shaping modern cancer research. He will be remembered as an inspiring researcher, dedicated mentor, and visionary leader. As a young physician in the 1950s, Paul Marks was fascinated

MSK’s fertility experts and nurse specialists counsel more than 800 patients every year. Their guidance gives patients hope that they can have a family — and helps them focus on the future.

… Friday, October 1, 2021 First came the news that Lauren Heuchling had a rare, life-threatening pediatric blood disorder . Her Memorial Sloan Kettering Cancer Center doctor, Farid Boulad, said she needed grueling treatment right away: chemotherapy and radiation, followed by a bone marrow transplant. Then

Learn about recent research led by MSK physician-scientist Luc Morris, who is trying to better predict who will benefit from immunotherapy.

… Thursday, November 4, 2021 How can oncologists better predict who will benefit from a widely used class of immunotherapy drugs called checkpoint inhibitors? In the precision medicine era of cancer care, it’s a question that has only increased in relevance. To answer it, a team including Luc Morris ,

A single prostate specific antigen (PSA) test taken before the age of 50 can be used to predict advanced prostate cancer in men up to 25 years in advance of a diagnosis, according to a new study published by researchers at Memorial Sloan Kettering Cancer Center in New York and Lund University in Sweden.

… Thursday, February 14, 2008 A single prostate specific antigen (PSA) test taken before the age of 50 can be used to predict advanced prostate cancer in men up to 25 years in advance of a diagnosis, according to a new study published by researchers at Memorial Sloan Kettering Cancer Center in New York

New research from MSK explores novel predictors of immunotherapy effectiveness against lung cancer; identifies how a high-fat diet hinders intestinal damage repair; reports findings from a clinical trial for people with androgen receptor-positive salivary gland cancer; and aims to understand the impact of tumor mutational burden on patients with locally advanced non-small cell lung cancer.

… Friday, January 20, 2023 New research from Memorial Sloan Kettering Cancer Center (MSK) and the Sloan Kettering Institute — MSK’s experimental research arm — explores novel predictors of immunotherapy effectiveness against lung cancer; identifies how a high-fat diet hinders intestinal damage repair;

Why do some patients respond to immunotherapy while others do not? Blood may hold the answer.

… Monday, April 10, 2017 Summary Some patients who receive immunotherapy drugs called checkpoint inhibitors experience significant benefit in terms of tumor shrinkage and longer survival — but many do not. A new study suggests that measuring changes in the blood could help doctors determine whether a person